PRAC recommends restricting use of prostate cancer medicine Xofigo
13.07.2018
more
Pharmacovigilance
Direct healthcare professional communication on the risk of occurrence of new primary malignancies associated with the use of XGEVA (denosumab)
17.05.2018
more
Direct healthcare professional communication on the increased rate of relapses of haematological malignancies and mortality in Hematopoietic Stem Cell Transplantation (HSCT) patients treated with azithromycin
02.05.2018
more
News from the CMDh meeting held in February 2018
16.04.2018
more
